CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas

Liling Liu(Sun Yat-sen University), Jing Zeng(Nextomics Biosciences (China)), Hao Duan(Sun Yat-sen University), Wanming Hu(Sun Yat-sen University), Lu Sun(Sun Yat-sen University), Jiahua He(University of California, San Francisco), Yuanzhong Yang(Sun Yat-sen University)
Frontiers in Oncology
April 15, 2021
10.3389/fonc.2021.611038
Cited by 34

Related Papers

The HDOCK server for integrated protein–protein docking
|Nature Protocols|2020|1.8k
Majorbio Cloud: A one‐stop, comprehensive bioinformatic platform for multiomics analyses
|iMeta|2022|857
Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer
|Autophagy|2023|387
Improvement of cryo-EM maps by simultaneous local and non-local deep learning
|Nature Communications|2023|209
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
|Viruses|2020|186